rs772746106

Variant summary

Our verdict is Uncertain significance. Variant got -1 ACMG points: 0P and 1B. BP4

This summary comes from the ClinGen Evidence Repository: The c.2957G>A (NM_006939.4(SOS2):c.2957G>A (p.Arg986Lys)) variant in SOS2 is a missense variant predicted to cause substitution of arginine by lysine at amino acid 986. The highest MAF in gnomAD v2.1.1 is 0.004629 % in the African/African American population (no population codes met). The computational predictor REVEL gives a score of 0.051, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7176917/MONDO:0021060/042

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

SOS2
NM_006939.4 missense, splice_region

Scores

1
2
16
Splicing: ADA: 0.3495
2

Clinical Significance

Uncertain significance reviewed by expert panel U:4B:1

Conservation

PhyloP100: 3.81
Variant links:
Genes affected
SOS2 (HGNC:11188): (SOS Ras/Rho guanine nucleotide exchange factor 2) This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got -1 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SOS2NM_006939.4 linkc.2957G>A p.Arg986Lys missense_variant, splice_region_variant Exon 18 of 23 ENST00000216373.10 NP_008870.2 Q07890-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SOS2ENST00000216373.10 linkc.2957G>A p.Arg986Lys missense_variant, splice_region_variant Exon 18 of 23 1 NM_006939.4 ENSP00000216373.5 Q07890-1
SOS2ENST00000543680.5 linkc.2858G>A p.Arg953Lys missense_variant, splice_region_variant Exon 17 of 22 1 ENSP00000445328.1 Q07890-2

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151672
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000157
AC:
3
AN:
190868
Hom.:
0
AF XY:
0.0000191
AC XY:
2
AN XY:
104760
show subpopulations
Gnomad AFR exome
AF:
0.0000773
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000213
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000403
AC:
54
AN:
1340620
Hom.:
0
Cov.:
23
AF XY:
0.0000315
AC XY:
21
AN XY:
667300
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000517
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151672
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74002
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000627
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4Benign:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Noonan syndrome 9 Uncertain:2
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 986 of the SOS2 protein (p.Arg986Lys). This variant is present in population databases (rs772746106, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with SOS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 475749). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
May 02, 2024
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.R986K variant (also known as c.2957G>A), located in coding exon 18 of the SOS2 gene, results from a G to A substitution at nucleotide position 2957. The arginine at codon 986 is replaced by lysine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

RASopathy Uncertain:1
Dec 03, 2024
ClinGen RASopathy Variant Curation Expert Panel
Significance: Uncertain significance
Review Status: reviewed by expert panel
Collection Method: curation

The c.2957G>A (NM_006939.4(SOS2):c.2957G>A (p.Arg986Lys)) variant in SOS2 is a missense variant predicted to cause substitution of arginine by lysine at amino acid 986. The highest MAF in gnomAD v2.1.1 is 0.004629 % in the African/African American population (no population codes met). The computational predictor REVEL gives a score of 0.051, which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). -

not provided Benign:1
May 13, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.39
T;.
Eigen
Benign
-0.047
Eigen_PC
Benign
0.16
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.69
T;T
M_CAP
Benign
0.0064
T
MetaRNN
Benign
0.19
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.77
N;.
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-2.2
N;N
REVEL
Benign
0.051
Sift
Benign
0.27
T;T
Sift4G
Benign
0.20
T;T
Polyphen
0.0010
B;.
Vest4
0.24
MutPred
0.40
Gain of ubiquitination at R986 (P = 0.0211);.;
MVP
0.40
MPC
0.20
ClinPred
0.28
T
GERP RS
5.4
Varity_R
0.58
gMVP
0.63

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.35
dbscSNV1_RF
Benign
0.30
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs772746106; hg19: chr14-50605331; COSMIC: COSV53563623; API